What’s New in Diagnostic Technology

講者: 楊旻鑫 醫師

PSMA-1007 對攝護腺癌治療決策 的影響(普瑞默)           

講者: 吳志毅 醫師

Update in Women’s Health

講者: 張瓈文 醫師

Progress in Men’s Health

講者: 蕭子玄 醫師

Endourology Innovations

講者: 劉品均 醫師

Robotic Surgery Update

講者: 潘　岳 醫師

Regeneration Medicine

講者: 蘇鴻麟 醫師

Pediatric Urology

講者: 黃欣媚 醫師

MIST Becomes a Mist? How to Select? &

講者: 洪健華 醫師

Optimizing Treatment Outcomes and Quality of Life in CSPC Patients with Enzalutamide

講者: 張家程 醫師

Perioperative Immunotherapy: A New Frontier in The Management of Muscle-Invasive Bladder Cancer Treatment

講者: 張沛泓 醫師

Innovation in Stone Management

講者: 李香瑩 醫師

Which Regimen for a Strong Start in mRCC? Bridging RealWorld Evidence and Personal Experience-(IPSEN)    

講者: 顏琮翰 醫師

Balancing Efficacy and Safety in Advanced Urothelial Carcinoma: Real-World Treatment Strategies-(默克)

講者: 陳國維 醫師

Case-Based Insights into Clinical Decision-Making in Advanced Urothelial Carcinoma –(默克)

講者: 蔡禮賢 醫師

PC Session: Advanced mCRPC Management – A New Era of Precision Targeting-(AZ)

講者: 洪晟鈞 醫師

Optimizing NMIBC Treatment Through Innovation Approach- (嬌生)

講者: 陳卷書 醫師

PSA Response as a Superior Predictor of Survival Beyond Testosterone Suppression -(武田)

講者: 陳正哲 醫師

Optimizing Oncological and Metabolic Outcomes in ADT: The Role of Stringent Testosterone Suppression and Cardiovascular Safety.-(IPSEN)

講者: 劉建良 醫師

Strategies for Maximizing Clinical Benefit with Eligard in Prostate Cancer Management- (健喬)

講者: 楊涵中 醫師

From Trial to Clinics: Treatment Consideration and Clinical Decision-Making in mCSPC-(嬌生)

講者: 王紹全 醫師

Current Application of PARP Inhibitor in Metastatic Prostate Cancer-(輝瑞)

講者: 陳盈伸 醫師